血糖値測定市場：製品、年齢層、用途、エンドユーザー、流通チャネル別-2025-2030年の世界予測

血糖値測定市場の2023年の市場規模は193億7,000万米ドルで、2024年には212億1,000万米ドルに達すると予測され、CAGR 9.76％で成長し、2030年には372億米ドルに達すると予測されています。

血糖値測定市場の対象範囲には、糖尿病管理に不可欠な血中グルコース濃度を測定する機器や技術が含まれます。適切な血糖値を維持することで合併症を防ぐことができるため、血糖値のモニタリングは糖尿病を効果的に管理するために必要です。このアプリケーションは、慢性疾患管理、在宅ヘルスケア、病院にまで広がっています。最終用途の範囲には、診断センター、ヘルスケア機関、自宅で自己測定する個人患者など多様な分野が含まれます。主な影響成長要因は、糖尿病有病率の増加、健康意識の高まり、技術の進歩、低侵襲または非侵襲製品へのシフトです。持続血糖モニター（CGM）やクラウドベースのプラットフォームと統合されたスマート医療機器の普及は、新たなビジネスチャンスをもたらしています。これらはリアルタイムのデータ分析を可能にし、患者の転帰を改善し、遠隔医療ソリューションのような斬新なビジネス提案を提供します。e-ヘルスとテーラーメイドの患者ケア戦略の拡大は、競争力の獲得を目指す市場リーダーにとって有望です。しかし、市場は、先進デバイスの高コスト、厳しい規制状況、データモニタリングに関連するプライバシーの懸念などの制限や課題に直面しています。さらに、技術的な依存性により、特に低資源環境での導入に格差が生じる可能性があります。技術革新と研究の機会には、精度と使いやすさを向上させた費用対効果の高いモデルの開発、特に低侵襲ソリューションをターゲットとしたものが含まれます。グルコース・モニタリングと他の健康指標を組み合わせた統合ウェルネス・プラットフォームのさらなる研究は、有益なイノベーション分野です。世界な共同研究は、研究努力の相乗効果、製品機能の充実、市場範囲の拡大につながります。市場力学はダイナミックで競争が激しく、急速な技術革新と消費者の高い期待を特徴としています。企業は、市場での存在感と成長を強化するために、消費者教育や手頃な価格戦略への投資と並行して、データ・セキュリティと規制遵守の強化に注力すべきです。

市場力学：急速に進化する血糖値測定市場の主要市場インサイトを公開

血糖値測定市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の糖尿病罹患率の上昇と効果的なグルコースモニタリングソリューションの必要性
  • 在宅ヘルスケアにおける非侵襲的な血糖値測定機器の採用増加
• 市場抑制要因
  • 血糖値測定デバイスの高コストと限られた精度
• 市場機会
  • 血糖値測定に対する政府の好意的な取り組みと償還政策
  • 血糖モニタリングデバイスの継続的な進歩と改良
• 市場の課題
  • 厳しい規制要件と製品回収事例

ポーターの5つの力：血糖値測定市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：血糖値測定市場における外部からの影響の把握

外部マクロ環境要因は、血糖値測定市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析血糖値測定市場における競合情勢の把握

血糖値測定市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス血糖値測定市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、血糖値測定市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨血糖値測定市場における成功への道筋を描く

血糖値測定市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 糖尿病発症の世界の増加と効果的な血糖モニタリングソリューションの必要性
    • 在宅ヘルスケア現場での非侵襲的血糖値測定デバイスの採用増加
  • 抑制要因
    • 血糖値測定デバイスの高コストと限られた精度
  • 機会
    • 血糖値測定に対する政府の有利な取り組みと償還政策
    • 血糖値モニタリング機器の継続的な進歩と改善
  • 課題
    • 厳しい規制要件と製品リコールの事例
• 市場セグメンテーション分析
  • 製品：重篤な短期および長期の糖尿病合併症を回避するための血糖値測定におけるCGMシステムの採用
  • 応用：妊娠糖尿病における血糖値測定の使用を増やし、いくつかの慢性疾患に関連するリスクを軽減する
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 血糖値測定市場：製品別

• グルコースメーター
  • 持続血糖モニタリング
  • フラッシュ血糖モニタリング
• インスリンペン
• インスリンポンプとリザーバー
• ランセット
• テストストリップ

第7章 血糖値測定市場：年齢層別

• 大人
• 老年医学
• 小児科

第8章 血糖値測定市場：用途別

• 妊娠糖尿病
• 1型糖尿病
• 2型糖尿病

第9章 血糖値測定市場：エンドユーザー別

• ホームケア
• 病院・クリニック

第10章 血糖値測定市場：流通チャネル別

• オフライン
• オンライン

第11章 南北アメリカの血糖値測定市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の血糖値測定市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの血糖値測定市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • Focus社はGlucoTrack社と協力し、埋め込み型持続血糖モニターを開発
  • Beurer Indiaがインド市場で血糖値モニター装置を発売
  • MTDがイプソメッドのペンニードルとBGM事業を買収し、糖尿病ケアにおける地位を強化
• 戦略分析と提言

企業一覧

• 77 Elektronika Kft.
• Abbott Laboratories
• ACON Laboratories, Inc
• AgaMatrix, Inc.
• ARKRAY, Inc.
• Ascensia Diabetes Care Holdings AG
• B. Braun Medical Ltd.
• Becton Dickinson and Company
• Beurer Belgium
• Dexcom, Inc.
• ForaCare Suisse AG
• i-SENS, Inc.
• Johnson & Johnson
• LifeScan IP Holdings, LLC
• Medisana AG
• Medtronic PLC
• Merck KGaA
• Microlife AG
• Neogen Corporation
• Nipro Corporation
• Nova Biomedical
• Omron Healthcare, Inc.
• Roche Diagnostics Nederland BV
• Rossmax International Ltd.
• Sanofi S.A.
• Sinocare Inc.
• Terumo Corporation
• Trividia Health, Inc.
• VivaChek Laboratories Inc.

LIST OF FIGURES

• FIGURE 1. BLOOD GLUCOSE TESTING MARKET RESEARCH PROCESS
• FIGURE 2. BLOOD GLUCOSE TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. BLOOD GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. BLOOD GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BLOOD GLUCOSE TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BLOOD GLUCOSE TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY FLASH GLUCOSE MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY INSULIN PUMPS & RESERVOIRS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY LANCETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 49. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 51. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 52. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 81. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 83. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 84. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 87. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 89. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 90. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 190. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 191. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 192. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 193. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 214. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 215. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 216. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 217. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 218. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 219. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 220. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 221. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 222. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 223. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 224. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 268. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 274. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 280. BLOOD GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 281. BLOOD GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Blood Glucose Testing Market was valued at USD 19.37 billion in 2023, expected to reach USD 21.21 billion in 2024, and is projected to grow at a CAGR of 9.76%, to USD 37.20 billion by 2030.

The scope of the blood glucose testing market involves devices and technologies that measure glucose levels in the blood, crucial for diabetes management. Blood glucose monitoring is necessary to manage diabetes effectively, as maintaining the appropriate blood glucose levels prevents complications. This application extends to chronic disease management, home healthcare, and hospitals. The end-use scope includes diverse sectors such as diagnostic centers, healthcare institutions, and individual patients self-monitoring at home. Key influencing growth factors are the increasing prevalence of diabetes, rising health awareness, advancements in technology, and the shift towards minimally invasive or non-invasive products. The widespread adoption of continuous glucose monitors (CGMs) and smart medical devices integrated with cloud-based platforms offers fresh opportunities. These allow real-time data analytics, improving patient outcomes and offering novel business proposals, such as telehealth solutions. The expansion of e-health and tailored patient-care strategies is promising for market leaders aiming to gain a competitive edge. However, the market faces limitations and challenges, such as the high costs of advanced devices, stringent regulatory landscapes, and privacy concerns associated with data monitoring. Moreover, technological dependency may result in disparities in adoption, particularly in low-resource settings. Opportunities for innovation and research include developing cost-effective models with enhanced accuracy and ease of use, especially targeting minimally invasive solutions. Further research into integrated wellness platforms that combine glucose monitoring with other health metrics is a lucrative innovation area. Global collaborations can lead to synergized research efforts, enriching product features and expanding market reach. The nature of the blood glucose testing market is dynamic and competitive, characterized by rapid technological changes and high consumer expectations. Firms should focus on enhancing data security and regulatory compliance, alongside investing in consumer education and affordable pricing strategies, to bolster market presence and growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Glucose Testing Market

The Blood Glucose Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Global rise in diabetes incidence and the need for effective glucose monitoring solutions
  • Rising adoption of non-invasive blood glucose testing devices in home healthcare settings
• Market Restraints
  • High costs and limited accuracy of blood glucose testing devices
• Market Opportunities
  • Favorable government initiatives and reimbursement policies for blood glucose testing
  • Ongoing advancements and improvements in blood glucose monitoring devices
• Market Challenges
  • Strict regulatory requirements and cases of product recalls

Porter's Five Forces: A Strategic Tool for Navigating the Blood Glucose Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Glucose Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Glucose Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Glucose Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Glucose Testing Market

A detailed market share analysis in the Blood Glucose Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Glucose Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Glucose Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Glucose Testing Market

A strategic analysis of the Blood Glucose Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Glucose Testing Market, highlighting leading vendors and their innovative profiles. These include 77 Elektronika Kft., Abbott Laboratories, ACON Laboratories, Inc, AgaMatrix, Inc., ARKRAY, Inc., Ascensia Diabetes Care Holdings AG, B. Braun Medical Ltd., Becton Dickinson and Company, Beurer Belgium, Dexcom, Inc., ForaCare Suisse AG, i-SENS, Inc., Johnson & Johnson, LifeScan IP Holdings, LLC, Medisana AG, Medtronic PLC, Merck KGaA, Microlife AG, Neogen Corporation, Nipro Corporation, Nova Biomedical, Omron Healthcare, Inc., Roche Diagnostics Nederland BV, Rossmax International Ltd., Sanofi S.A., Sinocare Inc., Terumo Corporation, Trividia Health, Inc., and VivaChek Laboratories Inc..

Market Segmentation & Coverage

This research report categorizes the Blood Glucose Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Glucose Meter, Insulin Pens, Insulin Pumps & Reservoirs, Lancets, and Test Strips. The Glucose Meter is further studied across Continuous Glucose Monitoring and Flash Glucose Monitoring.
• Based on Age Group, market is studied across Adults, Geriatrics, and Pediatrics.
• Based on Application, market is studied across Gestational Diabetes, Type 1 Diabetes, and Type 2 Diabetes.
• Based on End-User, market is studied across Home Care and Hospital & Clinics.
• Based on Distribution Channel, market is studied across Offline and Online.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Global rise in diabetes incidence and the need for effective glucose monitoring solutions
    • 5.1.1.2. Rising adoption of non-invasive blood glucose testing devices in home healthcare settings
  • 5.1.2. Restraints
    • 5.1.2.1. High costs and limited accuracy of blood glucose testing devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Favorable government initiatives and reimbursement policies for blood glucose testing
    • 5.1.3.2. Ongoing advancements and improvements in blood glucose monitoring devices
  • 5.1.4. Challenges
    • 5.1.4.1. Strict regulatory requirements and cases of product recalls
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Adoption of CGM systems in blood glucose to avoid serious, short- and long-term diabetes complications
  • 5.2.2. Application: Increasing uses of blood glucose testing in gestational diabetes to mitigate risks associated with several chronic diseases
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Blood Glucose Testing Market, by Product

• 6.1. Introduction
• 6.2. Glucose Meter
  • 6.2.1. Continuous Glucose Monitoring
  • 6.2.2. Flash Glucose Monitoring
• 6.3. Insulin Pens
• 6.4. Insulin Pumps & Reservoirs
• 6.5. Lancets
• 6.6. Test Strips

7. Blood Glucose Testing Market, by Age Group

• 7.1. Introduction
• 7.2. Adults
• 7.3. Geriatrics
• 7.4. Pediatrics

8. Blood Glucose Testing Market, by Application

• 8.1. Introduction
• 8.2. Gestational Diabetes
• 8.3. Type 1 Diabetes
• 8.4. Type 2 Diabetes

9. Blood Glucose Testing Market, by End-User

• 9.1. Introduction
• 9.2. Home Care
• 9.3. Hospital & Clinics

10. Blood Glucose Testing Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Offline
• 10.3. Online

11. Americas Blood Glucose Testing Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Blood Glucose Testing Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Blood Glucose Testing Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Focus collaborates with GlucoTrack on implantable continuous blood glucose monitor
  • 14.3.2. Beurer India launches blood glucose monitor device in the Indian market
  • 14.3.3. MTD acquires Ypsomed's Pen Needle and BGM Businesses, strengthening Its position in diabetes care
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 77 Elektronika Kft.
• 2. Abbott Laboratories
• 3. ACON Laboratories, Inc
• 4. AgaMatrix, Inc.
• 5. ARKRAY, Inc.
• 6. Ascensia Diabetes Care Holdings AG
• 7. B. Braun Medical Ltd.
• 8. Becton Dickinson and Company
• 9. Beurer Belgium
• 10. Dexcom, Inc.
• 11. ForaCare Suisse AG
• 12. i-SENS, Inc.
• 13. Johnson & Johnson
• 14. LifeScan IP Holdings, LLC
• 15. Medisana AG
• 16. Medtronic PLC
• 17. Merck KGaA
• 18. Microlife AG
• 19. Neogen Corporation
• 20. Nipro Corporation
• 21. Nova Biomedical
• 22. Omron Healthcare, Inc.
• 23. Roche Diagnostics Nederland BV
• 24. Rossmax International Ltd.
• 25. Sanofi S.A.
• 26. Sinocare Inc.
• 27. Terumo Corporation
• 28. Trividia Health, Inc.
• 29. VivaChek Laboratories Inc.